Home/Filings/4/0001209191-10-047764
4//SEC Filing

THIEL JEFFREY H 4

Accession 0001209191-10-047764

CIK 0001028318other

Filed

Sep 27, 8:00 PM ET

Accepted

Sep 28, 6:25 PM ET

Size

18.9 KB

Accession

0001209191-10-047764

Insider Transaction Report

Form 4
Period: 2010-09-27
Transactions
  • Disposition to Issuer

    Common Stock

    2010-09-279,2020 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$22.64/sh7,133$161,4550 total
    Exercise: $0.77Exp: 2013-06-24Common Stock (7,133 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$10.56/sh10,000$105,6000 total
    Exercise: $12.84Exp: 2018-09-16Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$5.89/sh10,000$58,9000 total
    Exercise: $17.51Exp: 2017-11-12Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$9.94/sh10,000$99,4000 total
    Exercise: $13.46Exp: 2019-09-15Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$5.72/sh10,000$57,2000 total
    Exercise: $17.68Exp: 2016-11-14Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-09-27$10.35/sh17,777$183,9920 total
    Exercise: $13.05Exp: 2014-06-24Common Stock (17,777 underlying)
Footnotes (2)
  • [F1]Pursuant to the Agreement and Plan of Merger, dated as of July 11, 2010, between Micrus Endovascular Corporation, Johnson & Johnson and Cope Acquisition Corp., each share of common stock held by the reporting person was converted into the right to receive $23.40 in cash, without interest.
  • [F2]Pursuant to the Agreement and Plan of Merger, dated as of July 11, 2010, between Micrus Endovascular Corporation, Johnson & Johnson and Cope Acquisition Corp., this stock option was converted into the right to receive an amount in cash per share subject to the stock option equal to the excess of the per share merger consideration of $23.40 over the per share exercise price of such stock option, without interest.

Issuer

MICRUS ENDOVASCULAR CORP

CIK 0001028318

Entity typeother

Related Parties

1
  • filerCIK 0001226357

Filing Metadata

Form type
4
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 6:25 PM ET
Size
18.9 KB